Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
methotrexate IV
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Generic mfg.
Drug class:
THF dehydrogenase inhibitor, Dihydrofolic acid reductase inhibitor
Related drugs:
‹
pemetrexed (58)
methotrexate (37)
pralatrexate (2)
pemetrexed RTD (1)
LX-101 (0)
pemetrexed (0)
methotrexate oral solution (0)
ADX-2191 (0)
pemetrexed (58)
methotrexate (37)
pralatrexate (2)
pemetrexed RTD (1)
LX-101 (0)
pemetrexed (0)
methotrexate oral solution (0)
ADX-2191 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login